If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

In 2023, nearly 1 in 4 US adults were living with chronic pain, and 8.5% experienced pain severe enough to limit daily life ...

A partnership between Sequel Med Tech and Senseonics creates the first automated insulin delivery system with a 1-year ...

Even among people with darker skin, continuing the drug during laser treatment was not seen to be associated with adverse ...

Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy ...

Rates of carpal tunnel syndrome are significantly higher in patients who later develop rheumatoid arthritis, according to an ...

A two-part communication strategy that included discussing vaccine concerns with skeptical parents was not effective in ...

While many nurses work set schedules with occasional overtime, Martha Mendez, a registered nurse (RN) in El Centro, ...

Nutritional counseling remains a central component of obesity treatment, even in the era of highly effective weight-loss ...

Many still believe that measles is a harmless disease and that vaccinations are more harmful, citing autism as a potential ...

TCAs, SNRIs, and alpha-2-delta ligands remain first-line treatments for neuropathic pain, while newer options like rTMS and ...

Rifaximin-alpha use decreases healthcare utilisation in patients with cirrhosis and hepatic encephalopathy, with fewer ...